Showing 1–7 of 7 results for author: Kyro, G W

A Hybrid Transformer Architecture with a Quantized Self-Attention Mechanism Applied to Molecular Generation

Authors: Anthony M. Smaldone, Yu Shee, Gregory W. Kyro, Marwa H. Farag, Zohim Chandani, Elica Kyoseva, Victor S. Batista

Abstract: The success of the self-attention mechanism in classical machine learning models has inspired the development of quantum analogs aimed at reducing computational overhead. Self-attention integrates learnable query and key matrices to calculate attention scores between all pairs of tokens in a sequence. These scores are then multiplied by a learnable value matrix to obtain the output self-attention… ▽ More The success of the self-attention mechanism in classical machine learning models has inspired the development of quantum analogs aimed at reducing computational overhead. Self-attention integrates learnable query and key matrices to calculate attention scores between all pairs of tokens in a sequence. These scores are then multiplied by a learnable value matrix to obtain the output self-attention matrix, enabling the model to effectively capture long-range dependencies within the input sequence. Here, we propose a hybrid quantum-classical self-attention mechanism as part of a transformer decoder, the architecture underlying large language models (LLMs). To demonstrate its utility in chemistry, we train this model on the QM9 dataset for conditional generation, using SMILES strings as input, each labeled with a set of physicochemical properties that serve as conditions during inference. Our theoretical analysis shows that the time complexity of the query-key dot product is reduced from $\mathcal{O}(n^2 d)$ in a classical model to $\mathcal{O}(n^2\log d)$ in our quantum model, where $n$ and $d$ represent the sequence length and embedding dimension, respectively. We perform simulations using NVIDIA's CUDA-Q platform, which is designed for efficient GPU scalability. This work provides a promising avenue for quantum-enhanced natural language processing (NLP). △ Less

Submitted 26 February, 2025; originally announced February 2025.

A Model-Centric Review of Deep Learning for Protein Design

Authors: Gregory W. Kyro, Tianyin Qiu, Victor S. Batista

Abstract: Deep learning has transformed protein design, enabling accurate structure prediction, sequence optimization, and de novo protein generation. Advances in single-chain protein structure prediction via AlphaFold2, RoseTTAFold, ESMFold, and others have achieved near-experimental accuracy, inspiring successive work extended to biomolecular complexes via AlphaFold Multimer, RoseTTAFold All-Atom, AlphaFo… ▽ More Deep learning has transformed protein design, enabling accurate structure prediction, sequence optimization, and de novo protein generation. Advances in single-chain protein structure prediction via AlphaFold2, RoseTTAFold, ESMFold, and others have achieved near-experimental accuracy, inspiring successive work extended to biomolecular complexes via AlphaFold Multimer, RoseTTAFold All-Atom, AlphaFold 3, Chai-1, Boltz-1 and others. Generative models such as ProtGPT2, ProteinMPNN, and RFdiffusion have enabled sequence and backbone design beyond natural evolution-based limitations. More recently, joint sequence-structure co-design models, including ESM3, have integrated both modalities into a unified framework, resulting in improved designability. Despite these advances, challenges still exist pertaining to modeling sequence-structure-function relationships and ensuring robust generalization beyond the regions of protein space spanned by the training data. Future advances will likely focus on joint sequence-structure-function co-design frameworks that are able to model the fitness landscape more effectively than models that treat these modalities independently. Current capabilities, coupled with the dizzying rate of progress, suggest that the field will soon enable rapid, rational design of proteins with tailored structures and functions that transcend the limitations imposed by natural evolution. In this review, we discuss the current capabilities of deep learning methods for protein design, focusing on some of the most revolutionary and capable models with respect to their functionality and the applications that they enable, leading up to the current challenges of the field and the optimal path forward. △ Less

Submitted 26 February, 2025; originally announced February 2025.

Quantum Machine Learning in Drug Discovery: Applications in Academia and Pharmaceutical Industries

Authors: Anthony M. Smaldone, Yu Shee, Gregory W. Kyro, Chuzhi Xu, Nam P. Vu, Rishab Dutta, Marwa H. Farag, Alexey Galda, Sandeep Kumar, Elica Kyoseva, Victor S. Batista

Abstract: The nexus of quantum computing and machine learning - quantum machine learning - offers the potential for significant advancements in chemistry. This review specifically explores the potential of quantum neural networks on gate-based quantum computers within the context of drug discovery. We discuss the theoretical foundations of quantum machine learning, including data encoding, variational quant… ▽ More The nexus of quantum computing and machine learning - quantum machine learning - offers the potential for significant advancements in chemistry. This review specifically explores the potential of quantum neural networks on gate-based quantum computers within the context of drug discovery. We discuss the theoretical foundations of quantum machine learning, including data encoding, variational quantum circuits, and hybrid quantum-classical approaches. Applications to drug discovery are highlighted, including molecular property prediction and molecular generation. We provide a balanced perspective, emphasizing both the potential benefits and the challenges that must be addressed. △ Less

Submitted 23 September, 2024; originally announced September 2024.

CardioGenAI: A Machine Learning-Based Framework for Re-Engineering Drugs for Reduced hERG Liability

Authors: Gregory W. Kyro, Matthew T. Martin, Eric D. Watt, Victor S. Batista

Abstract: The link between in vitro hERG ion channel inhibition and subsequent in vivo QT interval prolongation, a critical risk factor for the development of arrythmias such as Torsade de Pointes, is so well established that in vitro hERG activity alone is often sufficient to end the development of an otherwise promising drug candidate. It is therefore of tremendous interest to develop advanced methods for… ▽ More The link between in vitro hERG ion channel inhibition and subsequent in vivo QT interval prolongation, a critical risk factor for the development of arrythmias such as Torsade de Pointes, is so well established that in vitro hERG activity alone is often sufficient to end the development of an otherwise promising drug candidate. It is therefore of tremendous interest to develop advanced methods for identifying hERG-active compounds in the early stages of drug development, as well as for proposing redesigned compounds with reduced hERG liability and preserved on-target potency. In this work, we present CardioGenAI, a machine learning-based framework for re-engineering both developmental and commercially available drugs for reduced hERG activity while preserving their pharmacological activity. The framework incorporates novel state-of-the-art discriminative models for predicting hERG channel activity, as well as activity against the voltage-gated NaV1.5 and CaV1.2 channels due to their potential implications in modulating the arrhythmogenic potential induced by hERG channel blockade. We applied the complete framework to pimozide, an FDA-approved antipsychotic agent that demonstrates high affinity to the hERG channel, and generated 100 refined candidates. Remarkably, among the candidates is fluspirilene, a compound which is of the same class of drugs (diphenylmethanes) as pimozide and therefore has similar pharmacological activity, yet exhibits over 700-fold weaker binding to hERG. We envision that this method can effectively be applied to developmental compounds exhibiting hERG liabilities to provide a means of rescuing drug development programs that have stalled due to hERG-related safety concerns. We have made all of our software open-source to facilitate integration of the CardioGenAI framework for molecular hypothesis generation into drug discovery workflows. △ Less

Submitted 6 August, 2024; v1 submitted 12 March, 2024; originally announced March 2024.

ChemSpaceAL: An Efficient Active Learning Methodology Applied to Protein-Specific Molecular Generation

Authors: Gregory W. Kyro, Anton Morgunov, Rafael I. Brent, Victor S. Batista

Abstract: The incredible capabilities of generative artificial intelligence models have inevitably led to their application in the domain of drug discovery. Within this domain, the vastness of chemical space motivates the development of more efficient methods for identifying regions with molecules that exhibit desired characteristics. In this work, we present a computationally efficient active learning meth… ▽ More The incredible capabilities of generative artificial intelligence models have inevitably led to their application in the domain of drug discovery. Within this domain, the vastness of chemical space motivates the development of more efficient methods for identifying regions with molecules that exhibit desired characteristics. In this work, we present a computationally efficient active learning methodology that requires evaluation of only a subset of the generated data in the constructed sample space to successfully align a generative model with respect to a specified objective. We demonstrate the applicability of this methodology to targeted molecular generation by fine-tuning a GPT-based molecular generator toward a protein with FDA-approved small-molecule inhibitors, c-Abl kinase. Remarkably, the model learns to generate molecules similar to the inhibitors without prior knowledge of their existence, and even reproduces two of them exactly. We also show that the methodology is effective for a protein without any commercially available small-molecule inhibitors, the HNH domain of the CRISPR-associated protein 9 (Cas9) enzyme. We believe that the inherent generality of this method ensures that it will remain applicable as the exciting field of in silico molecular generation evolves. To facilitate implementation and reproducibility, we have made all of our software available through the open-source ChemSpaceAL Python package. △ Less

Submitted 3 December, 2023; v1 submitted 11 September, 2023; originally announced September 2023.

Quantum Convolutional Neural Networks for Multi-Channel Supervised Learning

Authors: Anthony M. Smaldone, Gregory W. Kyro, Victor S. Batista

Abstract: As the rapidly evolving field of machine learning continues to produce incredibly useful tools and models, the potential for quantum computing to provide speed up for machine learning algorithms is becoming increasingly desirable. In particular, quantum circuits in place of classical convolutional filters for image detection-based tasks are being investigated for the ability to exploit quantum adv… ▽ More As the rapidly evolving field of machine learning continues to produce incredibly useful tools and models, the potential for quantum computing to provide speed up for machine learning algorithms is becoming increasingly desirable. In particular, quantum circuits in place of classical convolutional filters for image detection-based tasks are being investigated for the ability to exploit quantum advantage. However, these attempts, referred to as quantum convolutional neural networks (QCNNs), lack the ability to efficiently process data with multiple channels and therefore are limited to relatively simple inputs. In this work, we present a variety of hardware-adaptable quantum circuit ansatzes for use as convolutional kernels, and demonstrate that the quantum neural networks we report outperform existing QCNNs on classification tasks involving multi-channel data. We envision that the ability of these implementations to effectively learn inter-channel information will allow quantum machine learning methods to operate with more complex data. This work is available as open source at https://github.com/anthonysmaldone/QCNN-Multi-Channel-Supervised-Learning. △ Less

Submitted 29 August, 2023; v1 submitted 30 May, 2023; originally announced May 2023.

HAC-Net: A Hybrid Attention-Based Convolutional Neural Network for Highly Accurate Protein-Ligand Binding Affinity Prediction

Authors: Gregory W. Kyro, Rafael I. Brent, Victor S. Batista

Abstract: Applying deep learning concepts from image detection and graph theory has greatly advanced protein-ligand binding affinity prediction, a challenge with enormous ramifications for both drug discovery and protein engineering. We build upon these advances by designing a novel deep learning architecture consisting of a 3-dimensional convolutional neural network utilizing channel-wise attention and two… ▽ More Applying deep learning concepts from image detection and graph theory has greatly advanced protein-ligand binding affinity prediction, a challenge with enormous ramifications for both drug discovery and protein engineering. We build upon these advances by designing a novel deep learning architecture consisting of a 3-dimensional convolutional neural network utilizing channel-wise attention and two graph convolutional networks utilizing attention-based aggregation of node features. HAC-Net (Hybrid Attention-Based Convolutional Neural Network) obtains state-of-the-art results on the PDBbind v.2016 core set, the most widely recognized benchmark in the field. We extensively assess the generalizability of our model using multiple train-test splits, each of which maximizes differences between either protein structures, protein sequences, or ligand extended-connectivity fingerprints of complexes in the training and test sets. Furthermore, we perform 10-fold cross-validation with a similarity cutoff between SMILES strings of ligands in the training and test sets, and also evaluate the performance of HAC-Net on lower-quality data. We envision that this model can be extended to a broad range of supervised learning problems related to structure-based biomolecular property prediction. All of our software is available as open source at https://github.com/gregory-kyro/HAC-Net/, and the HACNet Python package is available through PyPI. △ Less

Submitted 28 March, 2023; v1 submitted 23 December, 2022; originally announced December 2022.